Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2025-12-24 @ 5:31 PM
NCT ID:
NCT02523768
Eligibility Criteria:
Inclusion Criteria:
* Free, informed, express and written.
* Diagnosis of native kidney primary IgA glomerulonephritis biopsy-proven
* First kidney transplantation (one kidney)
Exclusion Criteria:
* Panel Reactive Antibody (PRA PRA global or class I or class II PRA) over 50% on a serum before transplantation
* Multi-organ graft
* Transplants using donor limits or sub-optimal: donor age ≥ 70 years, donors in the study BIGRAS or taken heart beating donors (tested on computer infusion) or other restriction factors
* IgA glomerulonephritis secondary to HSP (Henoch-Schonlein purpura) or Systemic Lupus Erythematosus (SLE) or alcoholic cirrhosis
* History of cancer older than 5 years or with advanced cancer, but except for non-recurrent skin cancers
* Infectious diseases scalable: tuberculosis, HIV, Hepatitis B virus or Hepatitis C virus infection with viral replication and / or chronic hepatitis
* Allergy to rabbit proteins
* Severe thrombocytopenia (\<50,000 platelets/ul)
* Bacterial infection, viral and fungal uncontrolled therapeutically
* Pregnancy or lactation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02523768
Study Brief:
Protocol Section:
NCT02523768